Diagnostic Performance of Greyscale Ultrasound in Detecting Fatty Liver Disease in a Type 2 Diabetes Population Using FibroScan as the Reference Standard.

Wiafe, Yaw A; Anyitey-Kokor, Ijeoma C; Nmai, Richmond A; Afihene, Mary; Roberts, Lewis R

Wiafe, Yaw A; Anyitey-Kokor, Ijeoma C; Nmai, Richmond A; Afihene, Mary; Roberts, Lewis R.

Afiliación

Wiafe YA; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, GHA.
Anyitey-Kokor IC; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, GHA.
Nmai RA; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, GHA.
Afihene M; School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, GHA.
Roberts LR; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, USA.

Cureus ; 15(6): e40756, 2023 Jun.

Article en En | MEDLINE | ID: mdl-37350981

Palabras clave

b-mode ultrasound; fatty liver disease; fibroscan; hepatic steatosis; nafld; non-alcoholic fatty liver disease; transient elastography; transient elastography (fibroscan); types 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google